Trimuda Nuansa Citra Tbk. vs Tempo Scan Pacific Tbk. — how do they compare? Trimuda Nuansa Citra Tbk. trades at Rp143 (market cap 59.03B, 495.2K 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,580 (market cap 11.68T, 429.7K 24h volume). The key difference: Tempo Scan Pacific Tbk. is far larger — about 197.9× Trimuda Nuansa Citra Tbk.'s market cap, and Trimuda Nuansa Citra Tbk. is more actively traded (495.2K versus 429.7K). Which is the better fit depends on your goals.
| TNCA | TSPC | |
|---|---|---|
Market Cap | 59.03B | 11.68T |
Volume | 495.2K | 429.7K |
Lot | 4.95K | 4.3K |
Turnover | 70.51M | 1.11B |
Average Price | 142.38 | 2,591.65 |
Value | 70.51M | 1.11B |
Indicative Equilibrium Price | 143 | 2,580 |
Indicative Equilibrium Volume | 9 | 100 |
Trailing returns across standard periods
Latest headlines on both assets
PT Trimuda Nuansa Citra Tbk(the Company) was established in Indonesia in accordance with Deed of Establishment of Limited Liability Company Company No. 21 dated May 4, 1995 made before H. Asmawel Amin, S.H., Notary in Jakarta.
Read more on TNCA →PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →